Skip to main navigation menu Skip to main content Skip to site footer

THE EFFECT OF CHEMICALS ON THE CAUSE OF HIGH BLOOD PRESSURE DISEASE, WHICH IS NOW COMMON

Abstract

Arterial hypertension, a pervasive and multifactorial cardiovascular disorder, continues to pose a significant global health challenge. This paper explores the intricate interplay between chemical exposures and the onset of arterial hypertension, shedding light on the diverse mechanisms through which various environmental and endogenous chemicals may contribute to the development and exacerbation of this disease. Emphasizing the importance of understanding chemical-induced vascular alterations, the review synthesizes current knowledge on the impact of pollutants, heavy metals, pharmaceuticals, and endocrine-disrupting chemicals on blood pressure regulation. Furthermore, it delves into the molecular pathways implicated in chemical-induced vascular dysfunction, oxidative stress, inflammation, and endothelial dysfunction. A comprehensive analysis of epidemiological studies and experimental models underscores the relevance of chemical exposures as potential risk factors for arterial hypertension. Ultimately, this review provides valuable insights into the complex relationship between chemical agents and the pathogenesis of arterial hypertension, offering a foundation for future research and preventive strategies.

Keywords

Arterial hypertension, cardiovascular disease, chemical exposures, environmental pollutants, heavy metals, pharmaceuticals, endocrine-disrupting chemicals, vascular dysfunction, oxidative stress, inflammation, endothelial dysfunction, blood pressure regulation, epidemiology, risk factors, preventive strategies.

DOWNLOAD PDF CERTIFICATE

References

  1. M.C. Acelajado, Z.H. Hughes, S. Oparil, D.A. Calhoun, Treatment of resistant and refractory hypertension
  2. C.C. Almenara, G.B. Broseghini-Filho, M.V. Vescovi, J.K. Angeli, O. Faria Tde, I. Stefanon, D.V. Vassallo, A.S. Padilha, Chronic cadmium treatment promotes oxidative stress and endothelial damage in isolated rat aorta
  3. H.A. Al-Naemi, S.C. Das, Cadmium-induced endothelial dysfunction mediated by asymmetric dimethylarginine
  4. Acelajado M.C., Hughes Z.H., Oparil S., Calhoun D.A. Treatment of resistant and refractory hypertension.
  5. Ahmad S.A., Khatun F., Sayed M.H., Khan M.H., Aziz R., Hossain M.Z., Faruquee M.H. Electrocardiographic abnormalities among arsenic-exposed persons through groundwater in Bangladesh. J. Health Popul. Nutr. 2006;24:221–227.
  6. Al-Abrash A.S., Al-Quobaili F.A., Al-Akhras G.N. Catalase evaluation in different human diseases associated with oxidative stress. Saudi Med. J. 2000;21:826–830.
  7. Atlas S.A. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J. Manag. Care Pharm. 2007;13:9–20.
  8. Mukhamedova, M., & Arnopolskaya, D. (2013). The Nitric Oxide System in Patients with Chronic Heart Failure. International Journal of Biomedicine, 3(3), 180-183.
  9. Alyavi, B., Mukhamedova, M., & Arnopolskaya, D. (2013). The Effects of Torasemide on Patients with Chronic Heart Failure. International Journal of Biomedicine, 3(1), 20-22.
  10. Тешаев, З. О., Абдурахманова, Н. Ф., & Мухамедова, М. Г. (2018). ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ И АСПЕКТЫ ЕЕ ЛЕЧЕНИЯ. In Научный поиск в современном мире (pp. 34-35).
  11. Фозилов, Х. Г., Шек, А. Б., Бекметова, Ф. М., Алиева, Р. Б., Мухамедова, М. Г., Муллабаева, Г. У., ... & Хотамова, М. Н. (2021). Особенности деформационных свойств левого желудочка у больных с поражением коронарных артерий. Клиническая и экспериментальная хирургия, 9(3), 118-124.
  12. Nasirova, G. A., & Mukhamedova, M. G. (2023). Chronic heart failure and COVID-19.
  13. Мухамедова, М. Г. (2023). Распространенность Электрокардиографических Предикторов Внезапной Смерти У Здоровых Мужчин Призывного Возраста. Central Asian Journal of Medical and Natural Science, 4(3), 1172-1180.
  14. Mukhamedova, M., Orziev, D. Z., Uzokov, J. K., & Abdullaev, A. X. (2023). Optimization of antiplatelet therapy in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions. European Journal of Cardiovascular Nursing, 22(Supplement_1), zvad064-111.
  15. Мухамедова, М. Г., & Арнопольская, Д. И. (2016). Эффекты петлевых диуретиков в базисной терапии хронической сердечной недостаточности. Журнал сердечная недостаточность, 17(1), 34-40.

Downloads

Download data is not yet available.